Announcement under Regulation 30 (LODR)-Newspaper Publication
Ravelcare Ltd operates in Personal Care within the Consumer Staples sector.
184 historical price candles were omitted because the exchange source has not been verified.
No red flags triggered.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Corporate actions, results dates and filings will appear here once ingested.
Latest exchange announcements, filings and downloadable documents.
No scheme among the 32 fund houses on record reported a position in Ravelcare Ltd. Portfolios are published monthly by each AMC; coverage is still partial.
Standalone figures
| Ratio | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2026 |
|---|---|---|---|---|
| Margins | ||||
| Gross margin % | 78.5% | 59.9% | 71.5% | 77.2% |
| EBITDA margin % | -26.6% | 14.3% | 30.4% | 26.2% |
| EBIT margin % | ||||
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Godrej Consumer Products LimitedGODREJCPGODREJCP | ₹85,949 Cr | ₹90,085 Cr | ₹16,050 Cr | ₹3,257 Cr | 20.8% | ₹2,052 Cr | 12.3% | 23.9% | 15.1% | 12 |
| Colgate Palmolive (India) LimitedCOLPALCOLPAL | ₹47,192 Cr | ₹47,192 Cr | ₹6,204 Cr | ₹1,900 Cr | 31% | ₹1,348 Cr | 22% | 106.4% | 81.6% | -188 |
| Cupid LimitedCUPIDCUPID | ₹42,022 Cr | ₹42,073 Cr | ₹453 Cr | ₹160 Cr | 32.6% | ₹137 Cr | 30.3% | 35.4% | 27.3% | 200 |
| Gillette India LimitedGILLETTEGILLETTE | ₹22,491 Cr | ₹22,491 Cr | ₹3,176 Cr | ₹961 Cr | 30.3% | ₹668 Cr | 21% | — | — | — |
| Procter & Gamble Hygiene And Health Care LimitedPGHHPGHH | ₹21,577 Cr | ₹21,577 Cr | ₹4,245 Cr | ₹1,075 Cr | 25.3% | ₹791 Cr | 18.6% | — | — | — |
| Emami LimitedEMAMILTDEMAMILTD | ₹16,266 Cr | ₹16,389 Cr | ₹3,915 Cr | ₹976 Cr | 25.5% | ₹748 Cr | 20.5% | 30.3% | 27.6% | 8 |
| Honasa Consumer LimitedHONASAHONASA | ₹13,950 Cr | ₹13,950 Cr | ₹2,553 Cr | ₹301 Cr | 9.9% | ₹249 Cr | 8.4% | 19.5% | 15.4% | -78 |
| Bajaj Consumer Care LimitedBAJAJCONBAJAJCON | ₹6,516 Cr | ₹6,516 Cr | ₹1,240 Cr | ₹264 Cr | 19% | ₹223 Cr | 16.3% | 30.5% | 25.3% | 42 |
| Recode Studios LtdRECODERECODE | ₹477 Cr | — | ₹80 Cr | ₹17 Cr | 20.7% | ₹11 Cr | 14% | — | — | — |
| Radix Industries (India) LtdRADIXINDRADIXIND | ₹193 Cr | ₹193 Cr | ₹48 Cr | ₹4 Cr | 7.6% | ₹3 Cr | 6.3% | 19.6% | 14.5% | 65 |
| H. R. Hygiene Products LtdHRHYGIENEHRHYGIENE | ₹143 Cr | — | — | — | — | — | — | — | — | — |
| Jhs Svendgaard Laboratories LimitedJHSJHS | ₹102 Cr | ₹117 Cr | ₹109 Cr | ₹3 Cr | 2.6% | ₹-2 Cr | -1.9% | -0.8% | -1.1% | 45 |
Documents link to external sources (exchange filings, company investor pages).
| -26.6% |
| 14.3% |
| 30.3% |
| 25.9% |
| PAT margin % | -35.4% | 16.1% | 23.1% | 19.1% |
| Working capital | ||||
| Receivable days | — | — | — | — |
| Inventory days | — | — | — | 90 |
| Payable days | — | — | — | — |
| NWC days | — | — | — | — |
| Leverage | ||||
| Current ratio | — | — | — | 45.23 |
| Debt to EBITDA | — | — | — | — |
| Debt to equity | — | — | — | — |
| Interest coverage | -21 | — | 98.3 | — |
| Asset turnover | — | — | — | 0.72 |
| Return ratios | ||||
| Return on assets % | — | — | — | 13.7% |
| Return on capital employed % | — | — | — | 18.9% |
| Return on equity % | — | — | — | — |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
| Holder (%) | Sep 2025 | Mar 2026 |
|---|---|---|
| 72.94% | 72.94% | |
| 3.54% | 2.57% | |
| 8.13% | 6.28% | |
| 0.34% | 0% | |
| 15.05% | 18.21% | |
| No. of shareholders | 470 | 363 |
Promoter holding up 0 percentage points since Sep 2025.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 3 Sept 2026 | VINEY GROWTH FUND | Bulk | BSE | Sell | 87,000 | ₹108.00 | ₹0.94 Cr |
| 3 Sept 2026 | VINEY EQUITY MARKET LLP | Bulk | BSE | Buy | 85,000 | ₹108.00 | ₹0.92 Cr |
| 2 Sept 2026 | VINEY GROWTH FUND | Bulk | BSE | Sell | 45,000 | ₹112.72 | ₹0.51 Cr |
| 2 Sept 2026 | VINEY EQUITY MARKET LLP | Bulk | BSE | Buy | 40,000 | ₹113.00 | ₹0.45 Cr |
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Announcement under Regulation 30 (LODR)-Newspaper Publication
Reg. 34 (1) Annual Report.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Appointment Of Secretarial Auditor
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Board Meeting Outcome for Outcome Of Board Meeting
| 26 Aug 2026, 9:01 pm | Company Update Press Release / Media Release | Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| 25 Aug 2026, 8:01 pm | Company Update General | Appointment Of Secretarial Auditor |
| 25 Aug 2026, 7:31 pm | Company Update Change in Registered Office Address | Announcement under Regulation 30 (LODR)-Change in Registered Office Address |
| 25 Aug 2026, 6:13 pm | Others Outcome without intimation | Board Meeting Outcome for Outcome Of Board Meeting |
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2026 |
|---|---|---|---|---|
| 1 | 3 | 22 | 27 | |
| COGS | 0 | 1 | 6 | 6 |
| Gross profit | 1 | 2 | 16 | 21 |
| 1 | 2 | 9 | 14 | |
| Operating profit (EBITDA) | -0 | 1 | 7 | 7 |
| OPM % | -26.6% | 14.3% | 30.4% | 26.2% |
| Depreciation | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | |
| Profit before tax | -0 | 1 | 7 | 7 |
| Tax | 0 | -0 | 2 | 2 |
| Tax % | 26.1% | -11.8% | 25.1% | 27.2% |
| -0 | 1 | 5 | 5 | |
| PAT margin % | -35.4% | 16.1% | 23.1% | 19.1% |
| EPS (₹) | -0.6 | 1.1 | 10.2 | 9.2 |
| ₹ Cr | Mar 2026 |
|---|---|
| Equity capital | — |
| Reserves | — |
| Borrowings | — |
| Other liabilities | 38 |
| Total equity & liabilities | 38 |
| Fixed assets | 0 |
| CWIP | — |
| Investments | 5 |
| 33 | |
| Total assets | 38 |
| ₹ Cr | Mar 2026 |
|---|---|
| -17 | |
| -4 | |
| 22 | |
| Net cash flow | 0 |
| Free cash flow | -20 |
| CFO / Operating profit % | -247.5% |